Expressions of Interest Now Open
This opportunity is offered by the Commonwealth under the Targeted Translation Research Accelerator (TTRA) Program which forms part of the Medical Research Future Fund (MRFF) to support the establishment of two Research Centres.
The TTRA Research Centres will accelerate therapies towards clinical practice for the prevention, diagnosis, treatment and management of disease-related complications for identified priorities associated with diabetes or cardiovascular disease, respectively.
Each Research Centre will be funded to a maximum of $10 million over four years. Partnerships and co-contributions are strongly encouraged and investigation in diverse clinical and therapeutic treatment modalities will be viewed favourably.
Each Research Centre must focus on at least two of the identified Priority Areas, with favourable recognition given to proposals addressing all three Priority Areas.
The Diabetes Research Centre’s translational research, development and implementation science activities must address at least two of the following Priority Areas:
- Priority 1: Diabetic kidney disease;
- Priority 2: Peripheral neuropathy and diabetic foot syndrome;
- Priority 3: Short-term complications of hypoglycaemia and/or hyperglycaemic hyperosmolar syndrome (HHS) and ketoacidosis.
The Cardiovascular Disease Research Centre’s translational research, development and implementation science activities must address at least two of the following Priority Areas:
- Priority 1: Coronary artery disease (including angina and MACE);
- Priority 2: Cardiomyopathy / heart failure;
- Priority 3: Transient ischaemic attack (TIA) / stroke (ischaemic and haemorrhagic).
The Research Centres must also demonstrate how adoption and implementation of their therapies will subsequently deliver health system outcomes, public health policy outcomes, consumer outcomes, commercial outcomes and reduce the burden of disease and health inequalities in Australia. It is expected that each Research Centre will have a strategy to become sustainable to ensure continued financial viability and talent management of the entity beyond the four years of TTRA funding. In addition to research and development, each Research Centre must include a training undertaking as part of its activities.
Please review the detailed Guidelines for further information about eligibility and the application process. All submissions must be made through SmartyGrants with a link provided below. The sample EOI application form provides an overview of what is required in your EOI.
Submissions will close at 16:00 AEDT on 15 March 2021.
For queries, please contact the TTRA team via email on firstname.lastname@example.org.